Transactions

Huawei’s 5G spinoff bluff shows why export ban will hurt US tech firms

CEO Ren Zhengfei doesn’t think another company can build a business around Huawei’s 5G technology stack. Not only will the company's predicament not help US tech firms, it is actively hurting them

Huawei’s 5G spinoff bluff shows why export ban will hurt US tech firms
20 Sep 2019

WiLAN patent purchase shows semiconductor space remains a happy hunting ground for NPEs

Deal with Mediatek involves package of global families and comes months after Canadian licensing company’s deal with Nvidia

20 Sep 2019

Territory, not technology, is Alibaba’s biggest challenge

The Jack Ma era has come to an end at the Chinese giant, leaving his successor to leverage the company’s data and services to establish a strong presence in the APAC region

Latest

View all
19 Sep 2019

Huawei picks up activity tracking portfolio from US firm  

In its first patent transaction closed since designation on the entity list, Chinese firm buys from Silicon Valley inventor credited with first camera phone picture Read more

16 Sep 2019

TiVo CEO: expect company split in first half of next year

Licensing business will take on company debt and needs to be “willing to litigate and litigate for years” Read more

16 Sep 2019

Kyocera scores another auto deal in haptics push

Litigation filed in Germany helped the Japanese electronics firm add auto supplier Preh to a list of licensees which already includes Robert Bosch Read more

12 Sep 2019

Huawei CEO: our 5G IP can be had for an upfront fee

Ren Zhengfei welcomes telecom equipment competition with a grandiose offer, but some key details are still open to question Read more

News

View all
11 Sep 2019

Five things to watch for from Japan’s new IP policy leadership

The new commissioner of the JPO and top cabinet advisor on IP will both address IPBC Asia in Tokyo in some of their first appearances in front of a global audience Read more

7 Sep 2019

Life sciences IP - the major developments in August

All the big pharma and biotech patent stories from last month in our regular monthly round-up Read more

28 Aug 2019

Asia's top IP owners revealed

Big filers, tough litigators and savvy dealmakers identified across eight industries in the run-up to IPBC Asia in Tokyo this October Read more

24 Aug 2019

Adversaries no more - licensors look to make deals, not settlements

In its day, the IPNav model was hugely successful in generating cash, but successful licensing in the here and now requires a different, less confrontational approach Read more

Analysis

View all
11 Sep 2019

We got it wrong on 2013 SEP guidance, says former USPTO Director Kappos, and the DOJ was right to walk away

Agency's ex-head claims the evidence of the last six years is that the assumptions underpinning the guidelines were flawed, while on the same day current chief Iancu says a new joint statement with the Justice Department remains under review    Read more

10 Sep 2019

Chinese investors dig into IP portfolios

Research reports in China increasingly highlight companies whose claims to innovation may not jibe with their patent portfolios Read more

9 Sep 2019

Latest patent deal numbers reveal that, for the first time in a decade, software has lost its lead

Healthcare and pharma takes top spot by number of transactions, with Industrial following in second place; while IBM was the biggest seller in Q2 Read more

9 Sep 2019

Why IBM’s latest open source move could benefit Chinese companies

Another royalty-free chip architecture becomes available as semiconductor self-sufficiency push continues Read more

Insights

View all
30 Aug 2019

IP market news highlights

Some of the major news stories carried on the IAM platform in June and July Read more

1 Apr 2019

IP market news highlights

The big stories from the IAM platform in February and March. Read more

30 Jan 2019

Apple v Qualcomm is the global patent fight for our times

Why Qualcomm’s winning of an injunction in China against Apple is another sign that the patent market is drifting inexorably eastwards. With the country’s answer to the Court of Appeals for the Federal Circuit opening at the start of this year, rights holders have even more reason to turn to Chinese courts. Read more

30 Nov 2018

After years of setting the patent agenda Silicon Valley is now playing defence

The USPTO director’s explicit rejection of the ‘troll’ narrative and the departure of key Congressional backers mean that big technology companies find themselves in the unusual position of not being in control of the US IP policy-making narrative. Read more

Find an expert

Vincent Thomas
Senior Managing Director
Chicago IL, United States
FTI Consulting Inc